ROKOS CAPITAL MANAGEMENT LLP – CRISPR Therapeutics AG Transaction History
ROKOS CAPITAL MANAGEMENT LLP portfolio value:
$5.86M
portfolio value
ROKOS CAPITAL MANAGEMENT LLP quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 369K | $65.35 | 87.5K | |
| Q2 2022 | share | 0.00% | 0 shares | -115K | $60.77 | 87.5K |